Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119977) titled 'Exploring the application of WASp activation-mediated enhancement of macrophage phagocytosis in glioblastoma therapy' on March 6.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: The First Affiliated Hospital of the Army Medical University
Condition:
Glioblastoma
Intervention:
High WASp activation group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-18
Target Sample Size: High WASp activation group:62;Low WASp activation group:62;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=312514...